Zou et al. [62, 63] |
Bioinformatic analysis of RNA-seq data sets (TCGA data from UCSC Cancer Genomics Hub) of 40-tumour-adjacent normal pairs and 363 additional unpaired tumors |
– 9681 lncRNA transcripts significantly changed; 596 lincRNAs of them strong dysregulated in HNSCC (up or downregulated)
– Confirmation of GAS5 and MEG3 down-regulation and identification of H19 and PCAT-1 dysregulation (all tumor sites)
-
– Different tumor sites analysis of 39 matched samples revealed:
OSCC – 777 lncRNAs changed
TSCC – 1020 lncRNAs changed
LSCC – 657 lncRNAs changed
– 276 lincRNAs significantly predict patients’ OS (over and underexpression depends on lincRNA);
– 256 associated with TP53 mutation and 269 with TP53-3p co-occurrence
|
Nohata et al. [64] |
Bioinformatic analysis of RNA-seq data sets (TCGA data from The Atlas of Noncoding RNAs in Cancer – TANRIC) of 468 tumor samples Analysis of sequencing data of OPC-22 panel (cell lines) |
– 728 lncRNA transcripts changed between normal and tumor samples (212 up- and 516 down-regulated)
– Significant connection of 55 lncRNAs with patient’s prognosis in OS or DFS (reduced or increased OS or DFS – depending on type of lncRNA)
– 27 upregulated lncRNAs in HPV+ cell lines and 140 up-regulated in HPV+ tumors from TCGA
– 30 lncRNAs downregulated in TP53 mutated tumors
|
Yang and Deng [65] |
Microarray analysis (mRNA and lncRNA) of 6 pairs of NPC and chronic nasopharyngitis (CNP) samples and qRT-PCR validation |
– 856 lncRNA transcripts changed between NPC and CNP (425 up- and 431 down-regulated)
– Changed lncRNA connected with apoptosis, cell growth and proliferation revealed by lncRNA-mRNA interaction analysis, migration and movement or cell differentiation and interaction with JAK-STAT signaling pathway
|
Zhang et al. [69] |
Microarray analysis of randomly paired 3 metastatic and 4 primary NPC tumor samples and qRT-PCR validation |
– 8088 lncRNA transcripts changed between metastatic and primary samples (3778 up-and 4310 down-regulated)
– Expression level of ENST00000438550 as an independent indicator of disease progression in NPC patients
|
Zhou et al. [74] |
Microarray analysis of 3 paired tumor and adjacent noncancerouse samples from hypopharyngeal squamose cell carcinoma (HSCC) patients and qRT-PCR validation |
– AB209630 and AB019562 indicated as changed in HNSCC (AB209630 low expressed, AB019562 high expressed), which influence on cell growth, colony formation, invasion and apoptosis/cell death in FaDu
– High expression of AB209630 correlated with better OS
|
Ren et al. [70] |
Next generation sequencing and qRT-PCR validation |
|
Zhang et al. [66] |
Bioinformatic analysis of microarray data sets (GSE25099 from Gene Expression Omnibus database) of 57 OSCC samples and 22 normal sample |
– 160 lncRNA transcripts changed between OSCC and normal samples (41 up- and 119 down-regulated)
– Up-regulated targets of lncRNA connected with immune response, response to wounding, inflammatory response and regulation of proliferation; down-regulated targets of lncRNA connected with epidermis development
|
Li et al. [73] |
Next generation sequencing and qRT-PCR of radio-resistant CNE-2-Rs and parental CNE-2 cell lines (nasopharengynal) and qRT-PCR validation |
– 310 up-regulated and 471 down-regulated of known lncRNAs in radioresistant CNE-2-Rs compared to parental CNE-2 cell line
– 3 novel lncRNA Unigene8485, Unigene8588 and down-regulated Unigene3434
– 13 pairs of lncRNA-mRNA associated with radioresistance in CNE-2-Rs cell line
|
Zhang et al. [75] |
Microarray analysis (lncRNA and mRNA) of 7 NPC tumor samples and adjacent non-tumor samples and qRT-PCR validation |
– 481 lncRNA transcripts changed between NPC and normal samples (231 up- and 250 down-regulated) as well as 766 mRNA transcripts (323 up- and 443 down-regulated)
– Up-regulated lncRNAs mainly localized on chromosomes: 12, 2, 1 (8.7% of lncRNA transcripts)
– LncRNA-mRNA pairs implicated in processes such as: regulation of transcription, macromolecule metabolic and biosynthesis, nerve development, immunological synapse or signaling pathways: B and T cell receptor transmembrane and TGF-β receptor
|